Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) FCF Margin (2016 - 2025)

Historic FCF Margin for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to 4.36%.

  • Angiodynamics' FCF Margin rose 25600.0% to 4.36% in Q4 2025 from the same period last year, while for Nov 2025 it was 3.13%, marking a year-over-year increase of 60500.0%. This contributed to the annual value of 4.99% for FY2025, which is 51000.0% up from last year.
  • As of Q4 2025, Angiodynamics' FCF Margin stood at 4.36%, which was up 25600.0% from 22.1% recorded in Q3 2025.
  • Over the past 5 years, Angiodynamics' FCF Margin peaked at 22.72% during Q2 2025, and registered a low of 33.92% during Q3 2023.
  • Its 5-year average for FCF Margin is 4.23%, with a median of 0.83% in 2023.
  • As far as peak fluctuations go, Angiodynamics' FCF Margin surged by 343600bps in 2021, and later crashed by -202000bps in 2022.
  • Angiodynamics' FCF Margin (Quarter) stood at 0.99% in 2021, then soared by 841bps to 7.36% in 2022, then plummeted by -30bps to 5.12% in 2023, then plummeted by -65bps to 1.8% in 2024, then soared by 143bps to 4.36% in 2025.
  • Its FCF Margin was 4.36% in Q4 2025, compared to 22.1% in Q3 2025 and 22.72% in Q2 2025.